SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Mar 17, 2015

IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: March 17, 2015 · CIK: 0001326205 · Accession: 0001185185-15-000533

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-201753, 333-201822

Date

March 17, 2015

Author

/s/ Spencer G. Feldman

Form

CORRESP

Company

IGC Pharma, Inc. (IGC) (CIK 0001326205)

Letter

Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 India Globalization Capital, Inc.

Re:

Dear Ms. Daniels:

Good morning Ms. Daniels.

Apologies as to the legal opinion filed with shelf registration statement on Form S-3 (No. 333-201822). A correct opinion is attached for your review. We intend to file just the opinion by amendment of Part II today or tomorrow.

May we then request acceleration for the selling shareholder registration statement on Form S-3 (No. 333-201753)?

Very truly yours,
/s/ Spencer G. Feldman

Show Raw Text

CORRESP
1
filename1.htm

    indiaglobal-corresp031715.htm

    March 17, 2015

Hillary Daniels, Esq.

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C.  20549

Re:

India Globalization Capital, Inc.

Dear Ms. Daniels:

Good morning Ms. Daniels.

Apologies as to the legal opinion filed with shelf registration statement on Form S-3 (No. 333-201822).  A correct opinion is attached for your review.  We intend to file just the opinion by amendment of Part II today or tomorrow.

May we then request acceleration for the selling shareholder registration statement on Form S-3 (No. 333-201753)?

Very truly yours,

/s/ Spencer G. Feldman

Spencer G. Feldman

SecProbe.io